Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : Mish's Global Economic Trend Analysis -- Ignore unavailable to you. Want to Upgrade?

To: Webster Groves who wrote (100523)	8/7/2009 1:28:32 PM
From: Elroy Jetson	1 Recommendation Respond to of 116555

It's unfortunate pharma firms don't find it practical to increase their spending on Research and Development. No doubt there are not many diseases left to be cured? Actually pharma research spending in any area is very low until someone else, perhaps a government scientist, discovers something new. Only then do many pharma firms sharply increase their spending, in that particular area, to develop a slightly different me-too version of the potential medication. If energy firms looked for energy the way pharma firms look for new treatments, pharma employees would be sitting in the dark after riding to work on a donkey. .